{"product_id":"pennantgroup-five-forces-analysis","title":"Pennant Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFrom Overview to Strategy Blueprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis brief snapshot highlights key competitive pressures facing Pennant but only scratches the surface. Unlock the full Porter's Five Forces Analysis to see force-by-force ratings, visuals, and actionable implications for strategy and investment. Get the complete, consultant-grade report to make confident, data-driven decisions about Pennant’s market position.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical labor scarcity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRegistered nurses, therapists and hospice clinicians remain tight pools—U.S. RN vacancy rates hovered around 8–10% in 2024—pushing wage inflation and agency premiums, with travel\/agency rates commonly 2–3x internal pay and adding 20–30% to labor spend during peaks. Staffing agencies gain leverage in flu season spikes; Pennant’s decentralized model helps local recruiting but shortages persist, while retention and training programs partly offset supplier power.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty drugs \u0026amp; DME\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLimited vendors for hospice meds, infusion therapies and DME give suppliers strong leverage; specialty drugs represented about 52% of US drug spend in 2024 (IQVIA) and the US DME market was roughly $65B in 2024. Contracting and formularies curb prices but FDA shortage listings and shipping disruptions can spike costs. Scale purchasing reduces unit costs, yet local availability in underserved markets and clinical-protocol constraints limit substitution.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReal estate \u0026amp; landlords\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePennant Porter depends on favorable leases and capital projects; large landlords and REITs can demand tougher terms in tight markets while oversupply shifts leverage back to operators. Rising rates—Fed funds ~5.25–5.50% and 10‑yr Treasury near 4% in 2024—increase rent escalators and tenant improvement costs. Decentralized site selection lets operators capture local discounts to reduce landlord leverage.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEHR and IT vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpclinical documentation billing and hospice emrs create high switching costs regulatory complexity with epic oracle cerner estimated to hold roughly of the u.s. inpatient ehr market in strengthening vendor bargaining power via mandated updates interoperability rising cybersecurity spend.\u003e\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003eMulti-year contracts limit price flexibility\u003c\/li\u003e\u003cli\u003eMandated updates and security needs increase vendor leverage\u003c\/li\u003e\u003cli\u003eModular tools and multi-vendor competition temper power\u003c\/li\u003e\n\u003c\/pclinical\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReferral sources as “supply”\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHospitals, physicians, and ACOs are the primary referral sources supplying patients to home health and hospice; high-quality CMS ratings and rapid response times reduce dependence on any single referrer. Preferred networks and value-based contracts (growing in 2024) give referrers leverage over volumes and clinical standards. Strong local relationships can rebalance power in underserved geographies.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReferrers: hospitals\/physicians\/ACOs\u003c\/li\u003e\n\u003cli\u003eLeverage: preferred networks\/value-based deals\u003c\/li\u003e\n\u003cli\u003eDefense: CMS ratings\/rapid response\u003c\/li\u003e\n\u003cli\u003eOpportunity: local relationships in underserved areas\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier power: RN vacancy \u003cstrong\u003e8-10%\u003c\/strong\u003e, agency 2-3x, specialty 52%, DME $65B\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers exert high power: RN vacancy 8–10% in 2024 driving 2–3x agency premiums and 20–30% labor spend spikes; specialty drugs ~52% of US drug spend and DME market ~$65B (2024) limit substitution. Landlords and EHR vendors (Epic\/Cerner 50–60% market share) add leverage; Pennant’s scale and local recruiting partially offset pressures.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRN vacancy\u003c\/td\u003e\n\u003ctd\u003e8–10%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAgency pay\u003c\/td\u003e\n\u003ctd\u003e2–3x internal\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty drugs\u003c\/td\u003e\n\u003ctd\u003e52% spend\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDME market\u003c\/td\u003e\n\u003ctd\u003e$65B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEHR share\u003c\/td\u003e\n\u003ctd\u003e50–60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003ePennant Porter's Five Forces analysis provides a tailored, data-driven assessment of competitive rivalry, supplier and buyer power, entry barriers and substitutes, and emerging disruptors—delivering strategic commentary and actionable insights in an editable Word format for investor materials, business plans, and internal strategy decks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise one-sheet Five Forces summary that quantifies competitive pressure, lets teams tweak inputs or market scenarios, generates instant radar charts, and exports clean visuals for decks—no macros or coding required for non-finance users.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare and Medicaid payers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePDGM, in place since 2020, pays home health by 30-day periods and, together with hospice Medicare payment rules, gives government payers dominant pricing power over Pennant Porter's post-acute and hospice lines.\u003c\/p\u003e\n\u003cp\u003eExtensive CMS compliance requirements and audits elevate administrative costs and constrain ability to negotiate rates with Medicare\/Medicaid.\u003c\/p\u003e\n\u003cp\u003eMedicaid reimbursement for senior living and HCBS is widely documented as lower than private pay, while scale and quality metrics (CMS star ratings, PDGM outcomes) aid network inclusion but do not raise baseline government-set rates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedicare Advantage plans\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedicare Advantage penetration rose to about 51% (≈32 million enrollees) in 2024, increasing buyer power through narrow networks and expanded prior authorization, tightening provider access and leverage. Plans push lower rates and shorter lengths of stay, shifting financial and clinical risk onto providers via capitation and utilization controls. Strong star ratings and outcomes data (bonus-linked) enhance plans' negotiating position, while local market share and unique access in underserved areas can secure favorable contract terms.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrivate-pay residents \u0026amp; families\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePrivate-pay residents compare price, amenities and care acuity tightly; median assisted-living rent was about $4,500\/month in 2024 and private-pay accounts for roughly 70% of demand. Switching costs exist but are manageable pre-move-in, increasing bargaining power. Transparent pricing and outcomes cut churn, while 2024 occupancy near 79% means supply surpluses drive discounting pressure during downturns.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealth systems and ACOs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDischarge planners and care coordinators strongly influence post-acute placement, steering patients toward preferred providers; preferred provider lists and bundled payment programs (BPCI Advanced: \u0026gt;1,000 participants) concentrate buyer leverage. Inclusion often depends on readmission performance and response times, with CMS readmission penalties up to 3% driving exclusion. Decentralized local operations that meet service-level expectations lock in steady referrals.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\u003c\/ul\u003e\n\u003cli\u003eDischarge planners steer placement\u003c\/li\u003e\n\u003cli\u003eBundled payments concentrate power (BPCI Advanced: \u0026gt;1,000 participants)\u003c\/li\u003e\n\u003cli\u003eCMS HRRP penalties up to 3% affect inclusion\u003c\/li\u003e\n\u003cli\u003eLocal service levels secure referrals\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice sensitivity in underserved markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cplower-income regions drive high price sensitivity as out-of-pocket costs often exceed of health spending in low-income countries bank forcing buyers into rate-taker behavior payer mixes tilt toward government programs limiting pricing power. demonstrable community impact sustains volumes despite narrow margins and targeted local outreach lowers buyer search churn.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eOut-of-pocket \u0026gt;30% (World Bank)\u003c\/li\u003e\n\u003cli\u003ePayer mix skew: high public program share\u003c\/li\u003e\n\u003cli\u003eCommunity impact sustains volume\u003c\/li\u003e\n\u003cli\u003eLocal outreach reduces churn and search costs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/plower-income\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePDGM and MA dominance (51%\/~32M) shift pricing power; private-pay fragility rises\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGovernment payers (PDGM, Medicare\/Medicaid) exert dominant price control since PDGM 2020; MA penetration ~51% (~32M enrollees) in 2024 heightens plan leverage. Private-pay sensitivity remains (median AL rent ~$4,500\/mo; occupancy ~79% in 2024), while discharge planners, BPCI Advanced (\u0026gt;1,000 participants) and CMS HRRP (up to 3% penalties) concentrate referral power and contract terms.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBuyer\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare Advantage\u003c\/td\u003e\n\u003ctd\u003ePenetration\u003c\/td\u003e\n\u003ctd\u003e51% (~32M)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAssisted living private-pay\u003c\/td\u003e\n\u003ctd\u003eMedian rent\u003c\/td\u003e\n\u003ctd\u003e$4,500\/mo\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOccupancy\u003c\/td\u003e\n\u003ctd\u003eRate\u003c\/td\u003e\n\u003ctd\u003e79%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003ePennant Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Pennant Porter's Five Forces Analysis you'll receive immediately after purchase—no surprises, no placeholders. The file is the full, professionally formatted analysis, ready to download and use the moment you buy. You're viewing the final deliverable; purchase grants instant access to this same document.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56163327476089,"sku":"pennantgroup-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/pennantgroup-five-forces-analysis.png?v=1762717481","url":"https:\/\/portersfiveforce.com\/products\/pennantgroup-five-forces-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}